Digital
JP Morgan 2024 – Simon Arkell interviewed by Jonah Comstock

JP Morgan 2024 – Simon Arkell

Generative AI – large language models, or LLMs, like ChatGPT – has the potential to revolutionise almost any knowledge industry, and pharma is no exception.

R&D
JP Morgan 2024 – Katherine Stueland and Jonah Comstock

JP Morgan 2024 – Katherine Stueland

Diagnostics can be a neglected part of the treatment paradigm, but it’s hugely important for connecting patients with the right treatments.

Sales & Marketing

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

Market Access

Editor's Picks

  1. GBL joins CVC in €10.7bn takeover bid for Recordati
  2. After refusing to resign, CDER head Høeg is fired
  3. As Ebola deaths climb, search begins for vaccine
  4. NICE changes stance on Genmab's cervical cancer drug
  5. Remepy's hybrid Parkinson's therapy poised for phase 3

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more